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MaAn 18-year-old primigravida woman underwent emergent percutaneous balloon stent repair of a severe coarctation of
the aorta, allowing her to undergo an uneventful remaining pregnancy and the delivery of a healthy baby. Her case also
demonstrates the association between maternal coarctation and fetal Shone complex. (Level of Difficulty: Beginner.)
(J Am Coll Cardiol Case Rep 2020;2:116–9) © 2020 The Authors. Published by Elsevier on behalf of the American College
of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).C oarctation of the aorta (COA) is usually diag-nosed in childhood, but 20% of cases do notpresent until adult life (1). Patients with COA
are increasingly reaching child-bearing age, and
pregnancy-related cardiovascular changes place addi-
tional stress on coarctation physiology (2). Unre-
paired COA in pregnancy can be life-threatening for
both mother and fetus. Maternal complications
include cerebral infarction, aortic dissection, aortic
rupture, congestive heart failure, hypertensive crisis,EARNING OBJECTIVES
To understand the risks of unrepaired COA
to the mother and to the fetus.
To identify indications for intervention in
cases of COA during pregnancy.
To appreciate that more research is needed
to determine the preferred invasive inter-
vention for emergent COA repair during
pregnancy.
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include growth retardation and premature birth with
increased risk for placental ischemia or abruption
(3,4).
When medical management with typical antihy-
pertensive drugs fails to decrease the coarctation
gradient, invasive intervention may be indicated (4).
Management of COA is dependent upon the patient’s
age, size (weight, length, andwidth of the coarctation),
and coarctation characteristics. Surgical resection is
recommended for neonates and young children.
Transcatheter treatment is preferred for adults and
children weighing more than 25 kg (5). Additional
cardiac defects may alter intervention strategy.
PRESENTATION
An 18-year-old primigravid woman presented at
11 weeks gestation with unrepaired COA and severe,
nonradiating substernal chest pain for 2 days. COA
had been diagnosed when she was 3 years old but had
been lost to follow-up for 3 years prior to the currenthttps://doi.org/10.1016/j.jaccas.2019.11.060
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AB BR E V I A T I O N S
AND ACRONYM S
COA = coarctation of the aorta
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117presentation. Her chest pain was associated with
dyspnea which worsened with exertion. Other
symptoms included orthopnea, palpitations, and
lightheadedness. Four extremity blood pressure
values included 128/76 mm Hg in the right upper
extremity; 133/79 mm Hg in the left upper extremity;
117/78 mm Hg in the right lower extremity; and 114/
74 mm Hg in the left lower extremity. On examina-
tion, a grade 3/6 systolic ejection murmur was heard
under her left scapula, and her lower extremity pulses
were difficult to palpate.
MEDICAL HISTORY
COA of the aorta had been diagnosed when the pa-
tient was 3 years old as bicuspid aortic valve and
anxiety.
DIFFERENTIAL DIAGNOSIS
Chest pain in a pregnant patient with history of COA
raises concerns for aortic aneurysm with dissection,
coronary artery dissection, pulmonary embolism,
pericarditis, or myocardial infarction. The presence of
an arm-leg blood pressure gradient suggests possible
severe COA or arterial occlusion from thrombosis or a
mass. Noncardiovascular causes of chest pain include
musculoskeletal chest wall pain, gastroesophageal
reflux, pneumonia, and anxiety.FIGURE 1 Suprasternal Echocardiographic Color Doppler Images Bef
(A) Prior to stent placement, the ascending aorta and transverse arch we
with a peak velocity of 3.5 m/s. (B) Flow is significantly improved acrosINVESTIGATIONS
Complete blood count and chemistry assay
results were unremarkable. Troponin level
was undetectable. Electrocardiography showed
normal sinus rhythm without ST-segment changes or
T-wave abnormalities. Chest radiography demon-
strated cardiomegaly with a mildly tortuous aorta.
Echocardiography demonstrated a dilated ascending
aorta and transverse arch with increased flow velocity
in the descending aorta despite attenuated abdominal
aortic pulsations and antegrade diastolic runoff
consistent with significant coarctation (Figure 1).
Biventricular function was normal.
MANAGEMENT
Emergent cardiac catheterization was performed with
the patient under general anesthesia with lead
shielding of the uterus. Significant distal aortic arch
narrowing was confirmed with the following mea-
surements: transverse arch: 17.1 mm; COA site:
8.5 mm; and descending aorta: 17.6 mm. Pre-
intervention peak-to-peak gradient was 15 mm Hg. A
Palmaz 3110 stent (Cordis Corp., Warren, New Jersey)
on an 18-  4-mm delivery balloon was implanted to
relieve the arch obstruction (Figure 2). The residual
gradient through the descending aorta after stent
placement was reduced to 0 mm Hg.ore and After Intervention
re dilated and aliased color flow across the coarctation site (arrow)
s the stented area, with a peak velocity of 1.5 m/s.
FIGURE 2 Angiographic Images Before and After Intervention
Lateral anterior oblique angiographic images demonstrate the coarctation before (A) and after (B) stent placement. Note the significant
change in aortic caliber and the lack of aortic wall injury.
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118The patient chose to continue the pregnancy after
being counseled about the uncertainty of the
outcome and her options of termination, surgical
intervention, catheterization, and medical manage-
ment. The patient was maintained on aspirin and
clopidogrel therapy. She was monitored closely with
frequent ultrasonograms, and the remainder of her
pregnancy was uneventful. Delivery proceeded
without bleeding complications.
DISCUSSION
This case demonstrates successful percutaneous
repair of COA during pregnancy by using a balloon
expandable stent. Management of COA during preg-
nancy is complicated by heightened procedural risks
to the pregnant woman and her fetus. For aortic
procedures, high estrogen levels can impact aortic
remodeling, predisposing the aorta to dissection and
rupture (3,6). However, if residual arch gradient is
low, outcomes of further pregnancies are favorable,
with rates of preeclampsia similar to those of the
general population (4).
Invasive intervention of aortic COA is usually
reserved for gradients of $20 mm Hg (7).
Gradients <20 mm Hg should be considered for
intervention when superimposed over heart struc-
tural defects, hypertension, heart failure, or a life-threatening symptom profile as seen in this patient
(7). Another point of consideration is the use of
fluoroscopy. Ideally, radiation should be avoided in
pregnancy as there is no safe dose, but in life-
threatening situations, such as significant COA, the
use of diagnostic examinations to preserve the life of
the mother can outweigh the risks. Specific pre-
cautions should be taken to limit fetal exposure to
radiation, including limiting fluoroscopic time and
positioning of the beam to avoid positioning the fetus
in a direct line (8).
When invasive intervention for COA is indicated,
treatment options include balloon angioplasty alone,
transcatheter stent implantation, and surgical coarc-
tectomy (4). To the best of the present authors’
knowledge, only one other transcatheter stent has
been successfully placed during pregnancy for treat-
ment of COA (3). Although further evidence is needed
to demonstrate a safety profile of stent placement in
pregnant patients for severe COA, the present case
provides a second example of successful implantation
with a good outcome.
Mothers with congenital heart disease, such as
COA, have an increased risk of having children with
congenital heart disease (6). Although the present
patient’s child during this presentation did not have
cardiac abnormalities, she later had 2 children with
Shone complex, which consists of left heart
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119obstructive lesions that may include COA, supra-
mitral stenosing ring, valvular aortic stenosis, and
subaortic stenosis. Left-sided obstructive lesions may
occur in 10% to 20% of first-degree relatives of pa-
tients with COA, in whom the ERBB4 and NOTCH1
genes are implicated in left ventricular outflow tract
abnormalities (1,9). Thus, a fetal echocardiogram
should be performed at 18 to 22 weeks gestation in
pregnant women with a history of COA (10). Early
detection can lead to improved outcomes for neo-
nates by allowing specialists to be present in care
prior to and immediately following birth.
FOLLOW-UP
The present patient is now a 24-year-old G5P3 healthy
woman. In addition to the child discussed, she has
had 2 living children with Shone complex and 2 mis-
carriages. Fetal echocardiography was performed foreach pregnancy, and the patient received genetic
counseling but declined further genetic testing.
CONCLUSIONS
Although further research is needed to determine the
safest interventions, management of this case
demonstrated a successful stent implantation for
treatment of severe COA in pregnancy. Pregnant pa-
tients with COA may benefit from genetic testing and
fetal echocardiographic screening for early detection
and intervention of cardiac defects in their offspring.
ADDRESS FOR CORRESPONDENCE: Dr. Mark H.
Hoyer, Indiana University School of Medicine, Divi-
sion of Pediatric Cardiology, 705 Riley Hospital Drive,
Riley 1134, Indianapolis, Indiana 46202. E-mail:
mhoyer@iu.edu.RE F E RENCE S1. Beauchesne LM, Connolly HM, Ammash NM,
Warnes CA. Coarctation of the aorta: outcome of
pregnancy. J Am Coll Cardiol 2001;38:1728–33.
2. Thilen U, Olsson SB. Pregnancy and heart dis-
ease: a review. Eur J Obstet Gynecol Reprod Biol
1997;75:43–50.
3. Assaidi A, Sbragia P, Fraisse A. Transcatheter
therapy for aortic coarctation with severe systemic
hypertension during pregnancy. Catheter Car-
diovasc Interv 2013;82:556.
4. Saeed SA, Dean S, Degiovanni JV. Not pre-
eclampsia. J Royal Society of Med 2001;94:351–3.
5. Dijkema EJ, Leiner T, Grotenhuis HB. Diagnosis,
imaging and clinical management of aortic coarc-
tation. Heart 2017;103:1148–55.6. Canobbio MM, Warnes CA, Alboulhosn J, et al.
Management of pregnancy in patients with complex
congenital heart disease: a scientific statement for
healthcare professionals from the American Heart
Association. Circulation 2017;135:e50–87.
7. Forbes TJ, Kim DW, Du W, et al. Comparison of
surgical, stent, and balloon angioplasty treatment
of native coarctation of the aorta: an observational
study by the CCISC. J Am Coll Cardiol 2011;58:
2664–74.
8. Tomà P, Bartoloni A, Salerno S, et al. Pro-
tecting sensitive patient groups from imaging
using ionizing radiation: effects during pregnancy,
in fetal life and childhood. Radiol Med 2019;124:
1–9.9. McBride KL, Zender GA, Fitzgerald-Butt SM,
et al. Association of common variants in ERBB4
with congenital left ventricular outflow tract
obstruction defects. Birth Defects Res 2011;91:
162.
10. Donofrio MT, Moon-Grady AJ, Hornberger LK,
et al. Diagnosis and treatment of fetal cardiac
disease: a scientific statement from the American
Heart Association. Circulation 2014 May 27;129:
2183–242.KEY WORDS balloon expanded stent,
coarctation of the aorta, pregnancy, Shone
complex
